Apixaban versus Warfarin in Atrial Fibrillation REPLY

被引：0
|
作者：
Mega, Jessica L. [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 366卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：89 / 90
页数：2
相关论文
共 50 条
  • [1] Apixaban versus Warfarin in Atrial Fibrillation
    Vassiliou, Vassilios S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01): : 88 - 88
  • [2] Apixaban versus Warfarin in Patients with Atrial Fibrillation
    Granger, Christopher B.
    Alexander, John H.
    McMurray, John J. V.
    Lopes, Renato D.
    Hylek, Elaine M.
    Hanna, Michael
    Al-Khalidi, Hussein R.
    Ansell, Jack
    Atar, Dan
    Avezum, Alvaro
    Cecilia Bahit, M.
    Diaz, Rafael
    Easton, J. Donald
    Ezekowitz, Justin A.
    Flaker, Greg
    Garcia, David
    Geraldes, Margarida
    Gersh, Bernard J.
    Golitsyn, Sergey
    Goto, Shinya
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Horowitz, John
    Mohan, Puneet
    Jansky, Petr
    Lewis, Basil S.
    Luis Lopez-Sendon, Jose
    Pais, Prem
    Parkhomenko, Alexander
    Verheugt, Freek W. A.
    Zhu, Jun
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11): : 981 - 992
  • [3] Critique of Apixaban Versus Warfarin in Patients With Atrial Fibrillation
    Nedeltchev, Krassen
    [J]. STROKE, 2012, 43 (03) : 922 - 923
  • [4] Apixaban versus warfarin in patients with atrial fibrillation: examination of ARISTOTLE
    Szczerba, Ewa
    [J]. KARDIOLOGIA POLSKA, 2012, 70 (02) : 196 - 200
  • [5] Atrial Fibrillation: Apixaban is superior to Warfarin
    Weiss, Johannes
    [J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2012, 80 (02) : 66 - 66
  • [6] Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation REPLY
    Patel, Manesh R.
    Fox, Keith A. A.
    Califf, Robert M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24): : 2335 - 2335
  • [7] Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
    Garcia, David A.
    Wallentin, Lars
    Lopes, Renato D.
    Thomas, Laine
    Alexander, John H.
    Hylek, Elaine M.
    Ansell, Jack
    Hanna, Michael
    Lanas, Fernando
    Flaker, Greg
    Commerford, Patrick
    Xavier, Denis
    Vinereanu, Dragos
    Yang, Hongqiu
    Granger, Christopher B.
    [J]. AMERICAN HEART JOURNAL, 2013, 166 (03) : 549 - 558
  • [8] Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
    Stanifer, John W.
    Pokorney, Sean D.
    Chertow, Glenn M.
    Hohnloser, Stefan H.
    Wojdyla, Daniel M.
    Garonzik, Samira
    Byon, Wonkyung
    Hijazi, Ziad
    Lopes, Renato D.
    Alexander, John H.
    Wallentin, Lars
    Granger, Christopher B.
    [J]. CIRCULATION, 2020, 141 (17) : 1384 - 1392
  • [9] Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation
    Bahit, M. Cecilia
    Lopes, Renato D.
    Wojdyla, Daniel M.
    Held, Claes
    Hanna, Michael
    Vinereanu, Dragos
    Hylek, Elaine M.
    Verheugt, Freek
    Goto, Shinya
    Alexander, John H.
    Wallentin, Lars
    Granger, Christopher B.
    [J]. HEART, 2017, 103 (08) : 623 - 628
  • [10] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    Bellolio, M. Fernanda
    McBane, Robert D.
    Shah, Nilay D.
    Noseworthy, Peter A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
12345